Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study found that white hair in vitiligo has specific patterns and structures, which vary with the stage of the disease and may be similar to another hair condition.

Vitiligo often runs in families and is linked to genetics and autoimmune factors.

People with vitiligo are more likely to also have alopecia areata.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Vitiligo may be linked to stopping finasteride.

The treatment improved hair color in most vitiligo patients without major side effects.

Hair transplantation showed the most promise for repigmenting white hair, especially for eyebrows and eyelashes.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

A boy's scalp infection, usually found on the body, was effectively treated with antifungal cream.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Surgical treatments for vitiligo are improving to enhance results and reduce costs.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

A new mouse model effectively mimics vitiligo for research and drug testing.

Combining treatments is key to managing vitiligo effectively.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Topical ruxolitinib quickly improves non-segmental vitiligo.

People with vitiligo may have a lower risk of heart disease.

Autologous mini-punch grafting can effectively repigment stable vitiligo, but has some risks and limitations.

Surgery can help treat vitiligo when other treatments don't work.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.